APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Anca Vasculitis Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Anca Vasculitis Drug Market Analysis and Forecast 2026-2032

Report ID 173963380219 December 2025190 pages

Choose your research edition.

Industry ResearchAnca Vasculitis Drug Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Anca Vasculitis Drug Industry Growth and Trends Forecast to 203273 pages · $3,450 USDMarket StructureGlobal Anca Vasculitis Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anca Vasculitis Drug Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Anca Vasculitis Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Anca Vasculitis Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Anca Vasculitis Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Anca Vasculitis Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Anca Vasculitis Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Anca Vasculitis Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Anca Vasculitis Drug include ChemoCentryx, Inc., Kineta, Inc. and GlaxoSmithKline plc, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Anca Vasculitis Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Anca Vasculitis Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Anca Vasculitis Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Anca Vasculitis Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Anca Vasculitis Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Anca Vasculitis Drug sales, projected growth trends, production technology, application and end-user industry.

Anca Vasculitis Drug Segment by Company

ChemoCentryx, Inc.

Kineta, Inc.

GlaxoSmithKline plc

Anca Vasculitis Drug Segment by Type

Dalazatide

Belimumab

CCX-168

CCX-1378

Others

Anca Vasculitis Drug Segment by Application

Hospital

Clinic

Others

Anca Vasculitis Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anca Vasculitis Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anca Vasculitis Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anca Vasculitis Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Anca Vasculitis Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Anca Vasculitis Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anca Vasculitis Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Anca Vasculitis Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Dalazatide Major Manufacturers Table 3. Belimumab Major Manufacturers Table 4. CCX-168 Major Manufacturers Table 5. CCX-1378 Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Anca Vasculitis Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Hospital Major Manufacturers Table 9. Clinic Major Manufacturers Table 10. Others Major Manufacturers Table 11. Anca Vasculitis Drug Industry Trends Table 12. Anca Vasculitis Drug Industry Drivers Table 13. Anca Vasculitis Drug Industry Opportunities and Challenges Table 14. Anca Vasculitis Drug Industry Restraints Table 15. Global Anca Vasculitis Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Anca Vasculitis Drug Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Anca Vasculitis Drug Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Anca Vasculitis Drug Revenue Market Share by Region (2021-2026) Table 19. Global Anca Vasculitis Drug Revenue Market Share by Region (2027-2032) Table 20. Global Anca Vasculitis Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 21. Global Anca Vasculitis Drug Sales by Region (2021-2026) & (K Units) Table 22. Global Anca Vasculitis Drug Sales by Region (2027-2032) & (K Units) Table 23. Global Anca Vasculitis Drug Sales Market Share by Region (2021-2026) Table 24. Global Anca Vasculitis Drug Sales Market Share by Region (2027-2032) Table 25. Global Anca Vasculitis Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Anca Vasculitis Drug Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Anca Vasculitis Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Anca Vasculitis Drug Sales Market Share by Manufacturers (2021-2026) Table 29. Global Anca Vasculitis Drug Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 30. Global Anca Vasculitis Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Anca Vasculitis Drug Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Anca Vasculitis Drug Manufacturers, Product Type & Application Table 33. Global Anca Vasculitis Drug Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Anca Vasculitis Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Anca Vasculitis Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Anca Vasculitis Drug Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Anca Vasculitis Drug Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Anca Vasculitis Drug Revenue Market Share by Type (2021-2026) Table 40. Global Anca Vasculitis Drug Revenue Market Share by Type (2027-2032) Table 41. Global Anca Vasculitis Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 42. Global Anca Vasculitis Drug Sales by Type (2021-2026) & (K Units) Table 43. Global Anca Vasculitis Drug Sales by Type (2027-2032) & (K Units) Table 44. Global Anca Vasculitis Drug Sales Market Share by Type (2021-2026) Table 45. Global Anca Vasculitis Drug Sales Market Share by Type (2027-2032) Table 46. Global Anca Vasculitis Drug Price by Type (2021-2026) & (US$/Unit) Table 47. Global Anca Vasculitis Drug Price by Type (2027-2032) & (US$/Unit) Table 48. Global Anca Vasculitis Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Anca Vasculitis Drug Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Anca Vasculitis Drug Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Anca Vasculitis Drug Revenue Market Share by Application (2021-2026) Table 52. Global Anca Vasculitis Drug Revenue Market Share by Application (2027-2032) Table 53. Global Anca Vasculitis Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 54. Global Anca Vasculitis Drug Sales by Application (2021-2026) & (K Units) Table 55. Global Anca Vasculitis Drug Sales by Application (2027-2032) & (K Units) Table 56. Global Anca Vasculitis Drug Sales Market Share by Application (2021-2026) Table 57. Global Anca Vasculitis Drug Sales Market Share by Application (2027-2032) Table 58. Global Anca Vasculitis Drug Price by Application (2021-2026) & (US$/Unit) Table 59. Global Anca Vasculitis Drug Price by Application (2027-2032) & (US$/Unit) Table 60. ChemoCentryx, Inc. Company Information Table 61. ChemoCentryx, Inc. Business Overview Table 62. ChemoCentryx, Inc. Anca Vasculitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 63. ChemoCentryx, Inc. Anca Vasculitis Drug Product Portfolio Table 64. ChemoCentryx, Inc. Recent Development Table 65. Kineta, Inc. Company Information Table 66. Kineta, Inc. Business Overview Table 67. Kineta, Inc. Anca Vasculitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Kineta, Inc. Anca Vasculitis Drug Product Portfolio Table 69. Kineta, Inc. Recent Development Table 70. GlaxoSmithKline plc Company Information Table 71. GlaxoSmithKline plc Business Overview Table 72. GlaxoSmithKline plc Anca Vasculitis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. GlaxoSmithKline plc Anca Vasculitis Drug Product Portfolio Table 74. GlaxoSmithKline plc Recent Development Table 75. North America Anca Vasculitis Drug Revenue by Type (2021-2026) & (US$ Million) Table 76. North America Anca Vasculitis Drug Revenue by Type (2027-2032) & (US$ Million) Table 77. North America Anca Vasculitis Drug Sales by Type (2021-2026) & (K Units) Table 78. North America Anca Vasculitis Drug Sales by Type (2027-2032) & (K Units) Table 79. North America Anca Vasculitis Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 80. North America Anca Vasculitis Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 81. North America Anca Vasculitis Drug Revenue by Application (2021-2026) & (US$ Million) Table 82. North America Anca Vasculitis Drug Revenue by Application (2027-2032) & (US$ Million) Table 83. North America Anca Vasculitis Drug Sales by Application (2021-2026) & (K Units) Table 84. North America Anca Vasculitis Drug Sales by Application (2027-2032) & (K Units) Table 85. North America Anca Vasculitis Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 86. North America Anca Vasculitis Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 87. North America Anca Vasculitis Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 88. North America Anca Vasculitis Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 89. North America Anca Vasculitis Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 90. North America Anca Vasculitis Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 91. North America Anca Vasculitis Drug Sales by Country (2021-2026) & (K Units) Table 92. North America Anca Vasculitis Drug Sales by Country (2027-2032) & (K Units) Table 93. North America Anca Vasculitis Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 94. North America Anca Vasculitis Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 95. United States Anca Vasculitis Drug Revenue (2021-2032) & (US$ Million) Table 96. Canada Anca Vasculitis Drug Revenue (2021-2032) & (US$ Million) Table 97. Europe Anca Vasculitis Drug Revenue by Type (2021-2026) & (US$ Million) Table 98. Europe Anca Vasculitis Drug Revenue by Type (2027-2032) & (US$ Million) Table 99. Europe Anca Vasculitis Drug Sales by Type (2021-2026) & (K Units) Table 100. Europe Anca Vasculitis Drug Sales by Type (2027-2032) & (K Units) Table 101. Europe Anca Vasculitis Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 102. Europe Anca Vasculitis Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 103. Europe Anca Vasculitis Drug Revenue by Application (2021-2026) & (US$ Million) Table 104. Europe Anca Vasculitis Drug Revenue by Application (2027-2032) & (US$ Million) Table 105. Europe Anca Vasculitis Drug Sales by Application (2021-2026) & (K Units) Table 106. Europe Anca Vasculitis Drug Sales by Application (2027-2032) & (K Units) Table 107. Europe Anca Vasculitis Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 108. Europe Anca Vasculitis Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 109. Europe Anca Vasculitis Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. Europe Anca Vasculitis Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 111. Europe Anca Vasculitis Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 112. Europe Anca Vasculitis Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 113. Europe Anca Vasculitis Drug Sales by Country (2021-2026) & (K Units) Table 114. Europe Anca Vasculitis Drug Sales by Country (2027-2032) & (K Units) Table 115. Europe Anca Vasculitis Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 116. Europe Anca Vasculitis Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 117. Germany Anca Vasculitis Drug Revenue (2021-2032) & (US$ Million) Table 118. France Anca Vasculitis Drug Revenue (2021-2032) & (US$ Million) Table 119. U.K. Anca Vasculitis Drug Revenue (2021-2032) & (US$ Million) Table 120. Italy Anca Vasculitis Drug Revenue (2021-2032) & (US$ Million) Table 121. Netherlands Anca Vasculitis Drug Revenue (2021-2032) & (US$ Million) Table 122. China Anca Vasculitis Drug Revenue by Type (2021-2026) & (US$ Million) Table 123. China Anca Vasculitis Drug Revenue by Type (2027-2032) & (US$ Million) Table 124. China Anca Vasculitis Drug Sales by Type (2021-2026) & (K Units) Table 125. China Anca Vasculitis Drug Sales by Type (2027-2032) & (K Units) Table 126. China Anca Vasculitis Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 127. China Anca Vasculitis Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 128. China Anca Vasculitis Drug Revenue by Application (2021-2026) & (US$ Million) Table 129. China Anca Vasculitis Drug Revenue by Application (2027-2032) & (US$ Million) Table 130. China Anca Vasculitis Drug Sales by Application (2021-2026) & (K Units) Table 131. China Anca Vasculitis Drug Sales by Application (2027-2032) & (K Units) Table 132. China Anca Vasculitis Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 133. China Anca Vasculitis Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 134. Asia Anca Vasculitis Drug Revenue by Type (2021-2026) & (US$ Million) Table 135. Asia Anca Vasculitis Drug Revenue by Type (2027-2032) & (US$ Million) Table 136. Asia Anca Vasculitis Drug Sales by Type (2021-2026) & (K Units) Table 137. Asia Anca Vasculitis Drug Sales by Type (2027-2032) & (K Units) Table 138. Asia Anca Vasculitis Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 139. Asia Anca Vasculitis Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 140. Asia Anca Vasculitis Drug Revenue by Application (2021-2026) & (US$ Million) Table 141. Asia Anca Vasculitis Drug Revenue by Application (2027-2032) & (US$ Million) Table 142. Asia Anca Vasculitis Drug Sales by Application (2021-2026) & (K Units) Table 143. Asia Anca Vasculitis Drug Sales by Application (2027-2032) & (K Units) Table 144. Asia Anca Vasculitis Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 145. Asia Anca Vasculitis Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 146. Asia Anca Vasculitis Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. Asia Anca Vasculitis Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 148. Asia Anca Vasculitis Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 149. Asia Anca Vasculitis Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 150. Asia Anca Vasculitis Drug Sales by Country (2021-2026) & (K Units) Table 151. Asia Anca Vasculitis Drug Sales by Country (2027-2032) & (K Units) Table 152. Asia Anca Vasculitis Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 153. Asia Anca Vasculitis Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 154. Japan Anca Vasculitis Drug Revenue (2021-2032) & (US$ Million) Table 155. South Korea Anca Vasculitis Drug Revenue (2021-2032) & (US$ Million) Table 156. India Anca Vasculitis Drug Revenue (2021-2032) & (US$ Million) Table 157. Australia Anca Vasculitis Drug Revenue (2021-2032) & (US$ Million) Table 158. China Taiwan Anca Vasculitis Drug Revenue (2021-2032) & (US$ Million) Table 159. Southeast Asia Anca Vasculitis Drug Revenue (2021-2032) & (US$ Million) Table 160. SAMEA Anca Vasculitis Drug Revenue by Type (2021-2026) & (US$ Million) Table 161. SAMEA Anca Vasculitis Drug Revenue by Type (2027-2032) & (US$ Million) Table 162. SAMEA Anca Vasculitis Drug Sales by Type (2021-2026) & (K Units) Table 163. SAMEA Anca Vasculitis Drug Sales by Type (2027-2032) & (K Units) Table 164. SAMEA Anca Vasculitis Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 165. SAMEA Anca Vasculitis Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 166. SAMEA Anca Vasculitis Drug Revenue by Application (2021-2026) & (US$ Million) Table 167. SAMEA Anca Vasculitis Drug Revenue by Application (2027-2032) & (US$ Million) Table 168. SAMEA Anca Vasculitis Drug Sales by Application (2021-2026) & (K Units) Table 169. SAMEA Anca Vasculitis Drug Sales by Application (2027-2032) & (K Units) Table 170. SAMEA Anca Vasculitis Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 171. SAMEA Anca Vasculitis Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 172. SAMEA Anca Vasculitis Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 173. SAMEA Anca Vasculitis Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 174. SAMEA Anca Vasculitis Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 175. SAMEA Anca Vasculitis Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 176. SAMEA Anca Vasculitis Drug Sales by Country (2021-2026) & (K Units) Table 177. SAMEA Anca Vasculitis Drug Sales by Country (2027-2032) & (K Units) Table 178. SAMEA Anca Vasculitis Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 179. SAMEA Anca Vasculitis Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 180. Brazil Anca Vasculitis Drug Revenue (2021-2032) & (US$ Million) Table 181. Argentina Anca Vasculitis Drug Revenue (2021-2032) & (US$ Million) Table 182. Chile Anca Vasculitis Drug Revenue (2021-2032) & (US$ Million) Table 183. Colombia Anca Vasculitis Drug Revenue (2021-2032) & (US$ Million) Table 184. Peru Anca Vasculitis Drug Revenue (2021-2032) & (US$ Million) Table 185. Saudi Arabia Anca Vasculitis Drug Revenue (2021-2032) & (US$ Million) Table 186. Israel Anca Vasculitis Drug Revenue (2021-2032) & (US$ Million) Table 187. UAE Anca Vasculitis Drug Revenue (2021-2032) & (US$ Million) Table 188. Turkey Anca Vasculitis Drug Revenue (2021-2032) & (US$ Million) Table 189. Iran Anca Vasculitis Drug Revenue (2021-2032) & (US$ Million) Table 190. Egypt Anca Vasculitis Drug Revenue (2021-2032) & (US$ Million) Table 191. Key Raw Materials Table 192. Raw Materials Key Suppliers Table 193. Anca Vasculitis Drug Distributors List Table 194. Anca Vasculitis Drug Customers List Table 195. Research Programs/Design for This Report Table 196. Authors List of This Report Table 197. Secondary Sources Table 198. Primary Sources List of Figures Figure 1. Anca Vasculitis Drug Image Figure 2. Global Anca Vasculitis Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anca Vasculitis Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Dalazatide Image Figure 5. Belimumab Image Figure 6. CCX-168 Image Figure 7. CCX-1378 Image Figure 8. Others Image Figure 9. Global Anca Vasculitis Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Anca Vasculitis Drug Market Size Share 2021 VS 2025 VS 2032 Figure 11. Hospital Image Figure 12. Clinic Image Figure 13. Others Image Figure 14. Global Anca Vasculitis Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Anca Vasculitis Drug Revenue (2021-2032) & (US$ Million) Figure 16. Global Anca Vasculitis Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Anca Vasculitis Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Anca Vasculitis Drug Revenue Market Share by Region (2021-2032) Figure 19. Global Anca Vasculitis Drug Sales (2021-2032) & (K Units) Figure 20. Global Anca Vasculitis Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 21. Global Anca Vasculitis Drug Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Anca Vasculitis Drug Sales YoY (2021-2032) & (K Units) Figure 23. Europe Anca Vasculitis Drug Sales YoY (2021-2032) & (K Units) Figure 24. China Anca Vasculitis Drug Sales YoY (2021-2032) & (K Units) Figure 25. Asia (Excluding China) Anca Vasculitis Drug Sales YoY (2021-2032) & (K Units) Figure 26. South America, Middle East and Africa Anca Vasculitis Drug Sales YoY (2021-2032) & (K Units) Figure 27. Global Anca Vasculitis Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Anca Vasculitis Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Anca Vasculitis Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Anca Vasculitis Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Anca Vasculitis Drug Revenue Market Share by Type (2021-2032) Figure 33. Global Anca Vasculitis Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 34. Global Anca Vasculitis Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Anca Vasculitis Drug Sales Market Share by Type (2021-2032) Figure 36. Global Anca Vasculitis Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Anca Vasculitis Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Anca Vasculitis Drug Revenue Market Share by Application (2021-2032) Figure 39. Global Anca Vasculitis Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 40. Global Anca Vasculitis Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Anca Vasculitis Drug Sales Market Share by Application (2021-2032) Figure 42. North America Anca Vasculitis Drug Revenue Share by Type (2021-2032) Figure 43. North America Anca Vasculitis Drug Sales Share by Type (2021-2032) Figure 44. North America Anca Vasculitis Drug Revenue Share by Application (2021-2032) Figure 45. North America Anca Vasculitis Drug Sales Share by Application (2021-2032) Figure 46. North America Anca Vasculitis Drug Revenue Share by Country (2021-2032) Figure 47. North America Anca Vasculitis Drug Sales Share by Country (2021-2032) Figure 48. Europe Anca Vasculitis Drug Revenue Share by Type (2021-2032) Figure 49. Europe Anca Vasculitis Drug Sales Share by Type (2021-2032) Figure 50. Europe Anca Vasculitis Drug Revenue Share by Application (2021-2032) Figure 51. Europe Anca Vasculitis Drug Sales Share by Application (2021-2032) Figure 52. Europe Anca Vasculitis Drug Revenue Share by Country (2021-2032) Figure 53. Europe Anca Vasculitis Drug Sales Share by Country (2021-2032) Figure 54. China Anca Vasculitis Drug Revenue Share by Type (2021-2032) Figure 55. China Anca Vasculitis Drug Sales Share by Type (2021-2032) Figure 56. China Anca Vasculitis Drug Revenue Share by Application (2021-2032) Figure 57. China Anca Vasculitis Drug Sales Share by Application (2021-2032) Figure 58. Asia Anca Vasculitis Drug Revenue Share by Type (2021-2032) Figure 59. Asia Anca Vasculitis Drug Sales Share by Type (2021-2032) Figure 60. Asia Anca Vasculitis Drug Revenue Share by Application (2021-2032) Figure 61. Asia Anca Vasculitis Drug Sales Share by Application (2021-2032) Figure 62. Asia Anca Vasculitis Drug Revenue Share by Country (2021-2032) Figure 63. Asia Anca Vasculitis Drug Sales Share by Country (2021-2032) Figure 64. SAMEA Anca Vasculitis Drug Revenue Share by Type (2021-2032) Figure 65. SAMEA Anca Vasculitis Drug Sales Share by Type (2021-2032) Figure 66. SAMEA Anca Vasculitis Drug Revenue Share by Application (2021-2032) Figure 67. SAMEA Anca Vasculitis Drug Sales Share by Application (2021-2032) Figure 68. SAMEA Anca Vasculitis Drug Revenue Share by Country (2021-2032) Figure 69. SAMEA Anca Vasculitis Drug Sales Share by Country (2021-2032) Figure 70. Anca Vasculitis Drug Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Anca Vasculitis Drug Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Dalazatide
  • Belimumab
  • CCX-168
  • CCX-1378
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • ChemoCentryx, Inc.
  • Kineta, Inc.
  • GlaxoSmithKline plc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Anca Vasculitis Drug Market by Type
  3. 1.2.1 Global Anca Vasculitis Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Dalazatide
  5. 1.2.3 Belimumab
  6. 1.2.4 CCX-168
  7. 1.2.5 CCX-1378
  8. 1.2.6 Others
  9. 1.3 Anca Vasculitis Drug Market by Application
  10. 1.3.1 Global Anca Vasculitis Drug Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Hospital
  12. 1.3.3 Clinic
  13. 1.3.4 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Anca Vasculitis Drug Market Dynamics
  1. 2.1 Anca Vasculitis Drug Industry Trends
  2. 2.2 Anca Vasculitis Drug Industry Drivers
  3. 2.3 Anca Vasculitis Drug Industry Opportunities and Challenges
  4. 2.4 Anca Vasculitis Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Anca Vasculitis Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Anca Vasculitis Drug Revenue by Region
  3. 3.2.1 Global Anca Vasculitis Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Anca Vasculitis Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Anca Vasculitis Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Anca Vasculitis Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Anca Vasculitis Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Anca Vasculitis Drug Sales by Region
  9. 3.4.1 Global Anca Vasculitis Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Anca Vasculitis Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Anca Vasculitis Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Anca Vasculitis Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Anca Vasculitis Drug Revenue by Manufacturers
  2. 4.1.1 Global Anca Vasculitis Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Anca Vasculitis Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Anca Vasculitis Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Anca Vasculitis Drug Sales by Manufacturers
  6. 4.2.1 Global Anca Vasculitis Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Anca Vasculitis Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Anca Vasculitis Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Anca Vasculitis Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Anca Vasculitis Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Anca Vasculitis Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Anca Vasculitis Drug Manufacturers, Product Type & Application
  13. 4.7 Global Anca Vasculitis Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Anca Vasculitis Drug Market CR5 and HHI
  16. 4.8.2 2025 Anca Vasculitis Drug Tier 1, Tier 2, and Tier 3
5 Anca Vasculitis Drug Market by Type
  1. 5.1 Global Anca Vasculitis Drug Revenue by Type
  2. 5.1.1 Global Anca Vasculitis Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Anca Vasculitis Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Anca Vasculitis Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Anca Vasculitis Drug Sales by Type
  6. 5.2.1 Global Anca Vasculitis Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Anca Vasculitis Drug Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Anca Vasculitis Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Anca Vasculitis Drug Price by Type
6 Anca Vasculitis Drug Market by Application
  1. 6.1 Global Anca Vasculitis Drug Revenue by Application
  2. 6.1.1 Global Anca Vasculitis Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Anca Vasculitis Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Anca Vasculitis Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Anca Vasculitis Drug Sales by Application
  6. 6.2.1 Global Anca Vasculitis Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Anca Vasculitis Drug Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Anca Vasculitis Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Anca Vasculitis Drug Price by Application
7 Company Profiles
  1. 7.1 ChemoCentryx, Inc.
  2. 7.1.1 ChemoCentryx, Inc. Company Information
  3. 7.1.2 ChemoCentryx, Inc. Business Overview
  4. 7.1.3 ChemoCentryx, Inc. Anca Vasculitis Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 ChemoCentryx, Inc. Anca Vasculitis Drug Product Portfolio
  6. 7.1.5 ChemoCentryx, Inc. Recent Developments
  7. 7.2 Kineta, Inc.
  8. 7.2.1 Kineta, Inc. Company Information
  9. 7.2.2 Kineta, Inc. Business Overview
  10. 7.2.3 Kineta, Inc. Anca Vasculitis Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Kineta, Inc. Anca Vasculitis Drug Product Portfolio
  12. 7.2.5 Kineta, Inc. Recent Developments
  13. 7.3 GlaxoSmithKline plc
  14. 7.3.1 GlaxoSmithKline plc Company Information
  15. 7.3.2 GlaxoSmithKline plc Business Overview
  16. 7.3.3 GlaxoSmithKline plc Anca Vasculitis Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 GlaxoSmithKline plc Anca Vasculitis Drug Product Portfolio
  18. 7.3.5 GlaxoSmithKline plc Recent Developments
8 North America
  1. 8.1 North America Anca Vasculitis Drug Market Size by Type
  2. 8.1.1 North America Anca Vasculitis Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Anca Vasculitis Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Anca Vasculitis Drug Price by Type (2021-2032)
  5. 8.2 North America Anca Vasculitis Drug Market Size by Application
  6. 8.2.1 North America Anca Vasculitis Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Anca Vasculitis Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Anca Vasculitis Drug Price by Application (2021-2032)
  9. 8.3 North America Anca Vasculitis Drug Market Size by Country
  10. 8.3.1 North America Anca Vasculitis Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Anca Vasculitis Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Anca Vasculitis Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Anca Vasculitis Drug Market Size by Type
  2. 9.1.1 Europe Anca Vasculitis Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Anca Vasculitis Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Anca Vasculitis Drug Price by Type (2021-2032)
  5. 9.2 Europe Anca Vasculitis Drug Market Size by Application
  6. 9.2.1 Europe Anca Vasculitis Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Anca Vasculitis Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Anca Vasculitis Drug Price by Application (2021-2032)
  9. 9.3 Europe Anca Vasculitis Drug Market Size by Country
  10. 9.3.1 Europe Anca Vasculitis Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Anca Vasculitis Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Anca Vasculitis Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Anca Vasculitis Drug Market Size by Type
  2. 10.1.1 China Anca Vasculitis Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Anca Vasculitis Drug Sales by Type (2021-2032)
  4. 10.1.3 China Anca Vasculitis Drug Price by Type (2021-2032)
  5. 10.2 China Anca Vasculitis Drug Market Size by Application
  6. 10.2.1 China Anca Vasculitis Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Anca Vasculitis Drug Sales by Application (2021-2032)
  8. 10.2.3 China Anca Vasculitis Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Anca Vasculitis Drug Market Size by Type
  2. 11.1.1 Asia Anca Vasculitis Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Anca Vasculitis Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Anca Vasculitis Drug Price by Type (2021-2032)
  5. 11.2 Asia Anca Vasculitis Drug Market Size by Application
  6. 11.2.1 Asia Anca Vasculitis Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Anca Vasculitis Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Anca Vasculitis Drug Price by Application (2021-2032)
  9. 11.3 Asia Anca Vasculitis Drug Market Size by Country
  10. 11.3.1 Asia Anca Vasculitis Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Anca Vasculitis Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Anca Vasculitis Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Anca Vasculitis Drug Market Size by Type
  2. 12.1.1 SAMEA Anca Vasculitis Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Anca Vasculitis Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Anca Vasculitis Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Anca Vasculitis Drug Market Size by Application
  6. 12.2.1 SAMEA Anca Vasculitis Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Anca Vasculitis Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Anca Vasculitis Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Anca Vasculitis Drug Market Size by Country
  10. 12.3.1 SAMEA Anca Vasculitis Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Anca Vasculitis Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Anca Vasculitis Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Anca Vasculitis Drug Value Chain Analysis
  2. 13.1.1 Anca Vasculitis Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Anca Vasculitis Drug Production Mode & Process
  6. 13.2 Anca Vasculitis Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Anca Vasculitis Drug Distributors
  9. 13.2.3 Anca Vasculitis Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst